Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.50 |
| ▸ | FADS1 | O60427 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27145735 | 0.78 | SOS1 (0.50) | ALDH1A1EPAS1RAB9ANPC1GAA | |
| SCHEMBL6351009 | 0.77 | MEN1 (0.54) | CYP1A2ALDH1A1CYP2C9CYP2C19L3MBTL1 | |
| SCHEMBL1704615 | 0.76 | MAPT (0.56) | CYP1A2ALDH1A1CYP2C9HPGDCYP2C19 | |
| SCHEMBL30785818 | 0.76 | MAPT (0.56) | CYP1A2ALDH1A1CYP2C9HPGDCYP2C19 | |
| SCHEMBL396120 | 0.75 | CXCL8 (0.55) | ALDH1A1HPGDMAPK10CDC25BRAB9A | |
| SCHEMBL29793294 | 0.75 | CXCL8 (0.55) | ALDH1A1HPGDMAPK10CDC25BRAB9A | |
| SCHEMBL16481437 | 0.73 | TAS2R14 (0.51) | ALDH1A1L3MBTL1RAB9AGAASMN1; SMN2 | |
| SCHEMBL11178333 | 0.72 | SMN1; SMN2 (0.56) | HPGDMAPK10RAB9ANPC1GAA | |
| SCHEMBL15129488 | 0.72 | TSHR (0.48) | ALDH1A1HPGDMAPK10CDC25BRAB9A | |
| SCHEMBL22923289 | 0.72 | MAPK10 (0.47) | CYP1A2ALDH1A1CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217917-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | THE UNIVERSITY OF STAVANGER (NO) | 2024-07-04 | — | — | US | disclosed |
| EP-4326704-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | The University of Stavanger (NO) | 2024-02-28 | — | — | EP | disclosed |
| WO-2022223390-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | THE UNIVERSITY OF STAVANGER (NO) | 2022-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217917-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | DDT, DDC, CTRC | CYP1A2 327/4885ALDH1A1 1873/4885CYP2C9 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.